Epithalon vs SNAP-8 (Acetyl Octapeptide-3)
A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Epithalon
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from Epithalamin, a polypeptide extract of the pineal gland. It has been studied since the 1980s by Russian researchers, primarily Vladimir Khavinson, for its ability to activate telomerase and extend telomere length — one of the few compounds with direct evidence of telomere elongation in human cells.
Full profileSNAP-8 (Acetyl Octapeptide-3)
8-amino acid cosmetic peptide active (Acetyl Octapeptide-3) that competes with SNARE complex proteins to reduce neuromuscular signal transmission in facial expression muscles. An extended, more potent version of Argireline (Acetyl Hexapeptide-3). Clinical studies show 26–63% reduction in expression wrinkle depth with twice-daily application, positioning it as a topical botulinum toxin alternative.
Full profile| Epithalon | SNAP-8 (Acetyl Octapeptide-3) | |
|---|---|---|
| Category | Anti-Aging & Longevity | Anti-Aging & Longevity |
| Also known as | Epitalon, Epithalone, Tetrapeptide Ala-Glu-Asp-Gly | Leuphasyl, Acetyl Octapeptide-3, SNAP-8 peptide, Argireline extension, Acetyl Glutamyl Heptapeptide-3 |
| Evidence | Research-stage | Research-stage |
| Dosing range | 5mg–20mg mg, daily for 10–20 day cycles, 1–2x per year | 1%–10% %, twice daily topical application |
| Administration | Subcutaneous injection, Intravenous (clinical studies), Intranasal | Topical (serum/cream) |
| Key side effects | Generally very well-tolerated, Injection site discomfort, Vivid dreams (commonly reported), Improved sleep depth (often reported as benefit) | Very well-tolerated, Rare mild skin irritation or redness, No systemic absorption at cosmetic concentrations, No paralysis risk (partial SNARE competition only) |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: Epithalon — Subcutaneous injection, Intravenous (clinical studies), Intranasal; SNAP-8 (Acetyl Octapeptide-3) — Topical (serum/cream).
- Dosing units differ: Epithalon is dosed in mg, SNAP-8 (Acetyl Octapeptide-3) in % — they operate at different scales.
- Frequency: Epithalon is typically daily for 10–20 day cycles, 1–2x per year; SNAP-8 (Acetyl Octapeptide-3) is twice daily topical application.
How each works
Epithalon
Epithalon activates telomerase (hTERT), the enzyme responsible for maintaining telomere length. In vitro and animal studies show telomere elongation, extended cell lifespan, and reduced DNA oxidation. Russian clinical studies in aging populations report improved melatonin rhythms, immune function, and reduced cancer incidence over multi-year follow-up.
SNAP-8 (Acetyl Octapeptide-3)
SNAP-8 mimics the N-terminal domain of SNAP-25, competing for SNARE complex assembly required for acetylcholine vesicle fusion at the neuromuscular junction. This partial inhibition reduces muscle contraction intensity without complete paralysis. Clinical studies demonstrate statistically significant reductions in crow's feet and forehead line depth after 28 days of use at 5–10% concentration.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.